Introduction
Calcium polystyrene sulfonate suspension 15g/60ml is an oral suspension formulated to treat hyperkalemia, a condition characterized by elevated potassium levels in the blood. Also referred to as calcium polystyrene sulfonate suspension, this medication acts as a potassium binder, helping to safely remove excess potassium and avoid related complications.
Mechanism of Action
This medication is a cation-exchange resin that works by releasing calcium ions in the gastrointestinal tract in exchange for potassium ions. When ingested, the resin passes through the stomach and small intestine, reaching the colon where it exchanges calcium ions for potassium ions present in the colon contents. The bound potassium is then eliminated through feces, effectively lowering serum potassium levels. This process is gradual and cumulative throughout the gut and helps reduce potassium reabsorption into the bloodstream.
Uses and Indications
Treatment of hyperkalemia associated with anuria or severe oliguria.
Management of hyperkalemia in patients requiring dialysis, including those on regular hemodialysis or prolonged peritoneal dialysis.
Prevention and control of elevated potassium levels in various clinical settings, especially chronic kidney disease.
Efficacy and Clinical Evidence
Clinical studies indicate that calcium polystyrene sulfonate effectively reduces serum potassium levels. One study found a significant potassium reduction (0.68 to 0.75 mmol/L) after 7 days of treatment with doses of 15g or 30g per day. The treatment was well tolerated, with a low incidence of gastrointestinal side effects like constipation. The resin's potassium-binding capacity allows effective elimination of potassium from the body, supporting its role as a safe and effective treatment for hyperkalemia.
Side Effects and Safety Profile
Common side effects may include:
Gastrointestinal disturbances such as constipation, nausea, vomiting, and loss of appetite.
Electrolyte imbalances including hypocalcemia, hypokalemia, and hypomagnesemia.
Rarely, serious intestinal injury including colonic necrosis has been reported.
Safety monitoring is advised, and the drug should be avoided in patients with obstructive bowel disease or reduced gut motility.
Contraindications and Precautions
Known hypersensitivity to calcium polystyrene sulfonate or any component of the formulation.
Patients with intestinal obstruction or severe constipation.
Use with caution in pregnancy and lactation due to limited data.
Avoid use in newborns with reduced gastrointestinal motility.
Drug Interactions
Calcium polystyrene sulfonate may bind to certain drugs in the gastrointestinal tract, reducing their absorption and effectiveness. These include lithium, thyroxine, and cardiac glycosides like digitalis. It is recommended to separate the administration of this resin and other oral medications by at least three hours to prevent interaction.
Warnings and Regulatory Status
The medication is for oral or rectal use only.
Used under medical supervision with regular serum electrolyte monitoring.
Approved and regulated as a treatment for hyperkalemia in many countries since the late 1950s.
Caution is warranted due to potential severe gastrointestinal adverse effects, particularly if combined with sorbitol.
Patient Advice and Tips
Take the suspension as directed by your healthcare provider, usually suspended in water or syrup, never in fruit juices containing potassium.
Maintain regular electrolyte monitoring during treatment.
Inform your doctor of all medications being taken to avoid interactions.
Report any abdominal pain, severe constipation, or unusual symptoms promptly.
Follow a low-potassium diet as advised to complement medication effectiveness.
Availability
Polystern Oral Suspension (Calcium Polystyrene Sulfonate 15g/60ml) is available in pharmacies and hospitals, marketed by pharmaceutical companies including Steris Healthcare Pvt Ltd.
Frequently Asked Questions
What is Polystern Oral Suspension used for?
It is used to treat high potassium levels in the blood (hyperkalemia).How does calcium polystyrene sulfonate work?
It works by exchanging calcium ions for potassium ions in the intestine, removing potassium from the body.Are there any serious side effects?
Rarely, it can cause severe intestinal damage; common side effects include gastrointestinal upset.Can I take other medicines with Polystern?
You should separate doses by at least three hours to avoid drug interactions.Is this medication safe during pregnancy?
Safety data are limited; use only if clearly needed and directed by a doctor.
Why Choose Steris Healthcare Pvt Ltd?
Steris Healthcare Pvt Ltd offers high-quality pharmaceutical products that meet stringent safety and efficacy standards. Their formulation of calcium polystyrene sulfonate suspension 15g/60ml ensures consistent potency, reliable manufacturing practices, and broad availability to support healthcare providers and patients managing hyperkalemia effectively.
Conclusion
Calcium polystyrene sulfonate suspension 15g/60ml, marketed as Polystern Oral Suspension, is a widely used and effective treatment for hyperkalemia. By binding potassium in the gut and promoting its elimination, it helps prevent serious complications of elevated potassium levels. Proper monitoring and adherence to dosing recommendations ensure safe use of this important medication.
